| scholarly article | Q13442814 |
| P2093 | author name string | Li M | |
| Wall RJ | |||
| Gruss P | |||
| St-Onge L | |||
| Furth PA | |||
| Hennighausen L | |||
| Garrett L | |||
| Wynshaw-Boris A | |||
| Wagner KU | |||
| P2860 | cites work | Tissue- and site-specific DNA recombination in transgenic mice | Q21999077 |
| Targeted oncogene activation by site-specific recombination in transgenic mice | Q24564632 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 | Q28236543 | ||
| Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites | Q28264411 | ||
| Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae | Q28288561 | ||
| A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells | Q29614542 | ||
| Inducible gene targeting in mice | Q29614544 | ||
| The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse | Q29618622 | ||
| A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice | Q33638859 | ||
| Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo | Q34163139 | ||
| Comparison of the whey acidic protein genra of the rat and mouse | Q34245576 | ||
| Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene | Q34560337 | ||
| Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice | Q34601019 | ||
| Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter | Q34612904 | ||
| Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. | Q35778832 | ||
| The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice | Q35793329 | ||
| Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase | Q40396045 | ||
| Lactogenic Hormone and Cell Type-Specific Control of the Whey Acidic Protein Gene Promoter in Transfected Mouse Cells | Q41659023 | ||
| Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system | Q42521403 | ||
| Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development | Q45789697 | ||
| Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line | Q46188484 | ||
| Expression of a whey acidic protein transgene during mammary development. Evidence for different mechanisms of regulation during pregnancy and lactation. | Q52237167 | ||
| Comparison of the regulation of the whey acidic protein gene with that of a hybrid gene containing the whey acidic protein gene promoter in transgenic mice. | Q52249832 | ||
| Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen | Q71246762 | ||
| Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation | Q71957674 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 4323-4330 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | Cre-mediated gene deletion in the mammary gland | |
| P478 | volume | 25 |
| Q36200972 | A Long-Lived Luminal Subpopulation Enriched with Alveolar Progenitors Serves as Cellular Origin of Heterogeneous Mammary Tumors |
| Q41664251 | A Unifying Theory of Branching Morphogenesis |
| Q36982090 | A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis. |
| Q90029662 | A mouse model engineered to conditionally express the progesterone receptor-B isoform |
| Q34589086 | A segmental deletion series generated by sister-chromatid transposition of Ac transposable elements in maize |
| Q33939630 | A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression |
| Q37631216 | A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis |
| Q36769677 | ATG proteins mediate efferocytosis and suppress inflammation in mammary involution |
| Q40076402 | ATM is required for SOD2 expression and homeostasis within the mammary gland. |
| Q42457867 | Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers |
| Q33897191 | Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. |
| Q28584971 | Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation |
| Q28087050 | Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration |
| Q52322881 | Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression. |
| Q90504024 | Alveolar progenitor cells in the mammary gland are dependent on the β4 integrin |
| Q33615688 | Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics |
| Q35112126 | Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. |
| Q64062826 | An ATF3-CreERT2 Knock-In Mouse for Axotomy-Induced Genetic Editing: Proof of Principle |
| Q36884758 | An Essential Role for Cdc42 in the Functioning of the Adult Mammary Gland |
| Q40374590 | An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance |
| Q52605706 | Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit. |
| Q36669208 | Analysis of lactation defects in transgenic mice |
| Q51356918 | Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors. |
| Q35157919 | Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models |
| Q37086261 | Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. |
| Q91117890 | B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model |
| Q36406519 | BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer |
| Q33699417 | Bcl-2 gene family and related proteins in mammary gland involution and breast cancer |
| Q36688779 | Biogenesis and function of mouse mammary epithelium depends on the presence of functional alpha-catenin |
| Q42377924 | Brown adipocytes can display a mammary basal myoepithelial cell phenotype in vivo |
| Q34425850 | CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland |
| Q57456357 | Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast |
| Q33947281 | Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells |
| Q39223363 | Characterization of WWOX inactivation in murine mammary gland development |
| Q47199203 | Characterization of mammary-specific disruptions for Tph1 and Lrp5 during murine lactation |
| Q34218211 | Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. |
| Q37069878 | Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer |
| Q35241200 | Comparison of radioimmuno and carbon nanotube field-effect transistor assays for measuring insulin-like growth factor-1 in a preclinical model of human breast cancer |
| Q36549790 | Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations |
| Q43814258 | Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation. |
| Q35986081 | Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. |
| Q37103753 | Conditional gene expression systems to study herpesvirus biology in vivo. |
| Q30496549 | Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation |
| Q34503454 | Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. |
| Q33761949 | Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function |
| Q35151873 | Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice |
| Q39301635 | Constitutive expression of microRNA-150 in mammary epithelium suppresses secretory activation and impairs de novo lipogenesis. |
| Q34485060 | Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution |
| Q37732569 | Coregulation of genetic programs by the transcription factors NFIB and STAT5. |
| Q47867267 | Cre recombinase-mediated gene targeting of mesenchymal cells |
| Q45103581 | Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models |
| Q36240642 | Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway. |
| Q35110797 | Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2. |
| Q28589097 | Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis |
| Q46218974 | Deletion of a coordinate regulator of type 2 cytokine expression in mice |
| Q36356105 | Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis |
| Q33853864 | Development of a unique system for spatiotemporal and lineage-specific gene expression in mice |
| Q48348820 | Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice |
| Q28585680 | Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A |
| Q33788940 | Differential requirement of GRP94 and GRP78 in mammary gland development. |
| Q28587922 | Disruption of the mouse necdin gene results in early post-natal lethality |
| Q57020648 | Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing |
| Q38275614 | E-cadherin's role in development, tissue homeostasis and disease: Insights from mouse models: Tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease |
| Q38904675 | EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival |
| Q34288822 | EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. |
| Q36328085 | ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex |
| Q52181362 | Efficient BLG-Cre mediated gene deletion in the mammary gland. |
| Q38678926 | Efficient gene activation in cultured mammalian cells mediated by FLP recombinase-expressing recombinant adenovirus |
| Q92643076 | Efficient tissue-type specific expression of target genes in a tetracycline-controlled manner from the ubiquitously active Eef1a1 locus |
| Q34516742 | Elevated mitochondrial superoxide disrupts normal T cell development, impairing adaptive immune responses to an influenza challenge |
| Q38356103 | Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. |
| Q47745236 | Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. |
| Q33556265 | Epidermal Smad4 deletion results in aberrant wound healing |
| Q36833386 | Epigenetic instability at imprinting control regions in a Kras(G12D)-induced T-cell neoplasm. |
| Q41524206 | Epigenetic response of imprinted domains during carcinogenesis |
| Q99603541 | Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development |
| Q35479646 | ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis |
| Q89697297 | Establishment and Characterization of a Brca1-/-, p53-/- Mouse Mammary Tumor Cell Line |
| Q37674501 | Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway |
| Q35777328 | Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice |
| Q35990241 | Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice |
| Q27309251 | Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer |
| Q26995224 | Expanding the scope of site-specific recombinases for genetic and metabolic engineering |
| Q24806283 | Experimental manipulation of radiographic density in mouse mammary gland |
| Q50316899 | Expression of the mRNA stability regulator Tristetraprolin is required for lactation maintenance in the mouse mammary gland |
| Q28584871 | Fatty acid synthase is required for mammary gland development and milk production during lactation |
| Q60321839 | Fog2 excision in mice leads to premature mammary gland involution and reduced Esr1 gene expression |
| Q33768293 | Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer |
| Q36106731 | FoxM1 regulates mammary luminal cell fate |
| Q33641744 | Foxa1 is essential for mammary duct formation. |
| Q91871605 | Fry Is Required for Mammary Gland Development During Pregnant Periods and Affects the Morphology and Growth of Breast Cancer Cells |
| Q34361027 | Functional activity of RLIM/Rnf12 is regulated by phosphorylation-dependent nucleocytoplasmic shuttling |
| Q77158823 | Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene |
| Q35885872 | Functions of myc:max in the control of cell proliferation and tumorigenesis |
| Q34573593 | Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation |
| Q52572633 | Gene targeting methods for studying nuclear transport factors in mice. |
| Q50483313 | Generation of Janus kinase 1 (JAK1) conditional knockout mice. |
| Q28585073 | Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice |
| Q34286291 | Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice |
| Q46605059 | Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. |
| Q33406237 | Genetic mechanisms in Apc-mediated mammary tumorigenesis |
| Q36670266 | Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development. |
| Q33578641 | Genetically engineered ERα-positive breast cancer mouse models |
| Q31112063 | Gpr177 deficiency impairs mammary development and prohibits Wnt-induced tumorigenesis |
| Q36957145 | HER3 is required for HER2-induced preneoplastic changes to the breast epithelium and tumor formation. |
| Q42484138 | Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin |
| Q36843802 | Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression |
| Q45246446 | High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands. |
| Q27312162 | Huntingtin Is Required for Epithelial Polarity through RAB11A-Mediated Apical Trafficking of PAR3-aPKC |
| Q53530644 | IKKalpha is required to maintain skin homeostasis and prevent skin cancer. |
| Q34348008 | Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice |
| Q35171080 | In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro |
| Q48216942 | In vivo reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling |
| Q37104726 | Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models |
| Q37493064 | Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation |
| Q59137669 | Inhibition of AKT suppresses the initiation and progression of -associated mammary tumors |
| Q58786210 | Inhibition of Estrogen Signaling Reduces the Incidence of -associated Mammary Tumor Formation |
| Q102379359 | Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo |
| Q35676688 | Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo |
| Q42678959 | Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue |
| Q37122579 | Janus Kinase 1 Is Essential for Inflammatory Cytokine Signaling and Mammary Gland Remodeling. |
| Q93274029 | Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression |
| Q28588240 | Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer |
| Q24802378 | Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer? |
| Q36512944 | Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer |
| Q37416013 | Longitudinal analysis of mammogenesis using a novel tetracycline-inducible mouse model and in vivo imaging. |
| Q60950454 | Loss of BRCA1 Spontaneously Induces the Tumorigenesis in Lacrimal Gland |
| Q35558962 | Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice |
| Q36422318 | Loss of BRCA1 leads to an increased sensitivity to Bisphenol A. |
| Q48006079 | Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. |
| Q36160621 | Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes. |
| Q64057070 | Loss of Fam20c causes defects in the acinar and duct structure of salivary glands in mice |
| Q34522002 | Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment |
| Q99605770 | Loss of Proprotein Convertase Furin in Mammary Gland Impairs proIGF1R and proIR Processing and Suppresses Tumorigenesis in Triple Negative Breast Cancer |
| Q34300607 | Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden. |
| Q47970005 | Loss of connexin 26 in mammary epithelium during early but not during late pregnancy results in unscheduled apoptosis and impaired development |
| Q45988712 | Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation. |
| Q52051392 | Loss of the LIM domain protein Lmo4 in the mammary gland during pregnancy impedes lobuloalveolar development. |
| Q33587338 | Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice |
| Q43909419 | Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility |
| Q36702175 | Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. |
| Q28250940 | MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer |
| Q34647947 | MMTV-Cre transgenes can adversely affect lactation: considerations for conditional gene deletion in mammary tissue |
| Q90673081 | MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma |
| Q36084382 | Mammary Epithelial Cell Lineage Analysis via the Lyon's Hypothesis. |
| Q38964566 | Mammary alveolar epithelial cells convert to brown adipocytes in post-lactating mice |
| Q37576068 | Mammary extracellular matrix directs differentiation of testicular and embryonic stem cells to form functional mammary glands in vivo |
| Q33837757 | Mammary gland specific knockdown of the physiological surge in Cx26 during lactation retains normal mammary gland development and function |
| Q33682960 | Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation |
| Q24645591 | Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation |
| Q34990925 | Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice |
| Q36600478 | Manganese superoxide dismutase is dispensable for post-natal development and lactation in the murine mammary gland |
| Q34144845 | Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice |
| Q37568407 | MiR-193b and miR-365-1 are not required for the development and function of brown fat in the mouse |
| Q40599114 | MicroPET imaging of Cre-loxP-mediated conditional activation of a herpes simplex virus type 1 thymidine kinase reporter gene |
| Q27321385 | Miz1 deficiency in the mammary gland causes a lactation defect by attenuated Stat5 expression and phosphorylation |
| Q91891592 | Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy |
| Q37051766 | Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland |
| Q34667643 | Modelling breast cancer: one size does not fit all. |
| Q24803741 | Models of breast cancer: quo vadis, animal modeling? |
| Q33923742 | Modification and repression of genes expressed in the mammary gland using gene targeting and other technologies |
| Q50093958 | Mouse Models of Erythropoiesis and Associated Diseases. |
| Q42137028 | Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo |
| Q24797754 | Mouse models for breast cancer |
| Q36602578 | Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects |
| Q38055069 | Mouse models of BRCA1 and their application to breast cancer research |
| Q38079299 | Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors. |
| Q42472188 | Mouse models of breast cancer |
| Q34553964 | Mouse models of breast cancer metastasis |
| Q36451974 | N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland |
| Q33699422 | NF-kappaB and apoptosis in mammary epithelial cells |
| Q29614484 | NIX is required for programmed mitochondrial clearance during reticulocyte maturation |
| Q35057667 | Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland |
| Q37690101 | New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells. |
| Q90598191 | Normal mammary gland development after MMTV-Cre mediated conditional PAK4 gene depletion |
| Q97686592 | Notch activation in the mouse mammary luminal lineage leads to ductal hyperplasia and altered partitioning of luminal cell subtypes |
| Q36382641 | Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor |
| Q30417842 | Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ducts |
| Q33616502 | Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation |
| Q92534377 | PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer |
| Q38718336 | PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α. |
| Q28508026 | Paracrine-rescued lobulogenesis in chimeric outgrowths comprising progesterone-receptor-null mammary epithelium and redirected wild-type testicular cells |
| Q50701525 | Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. |
| Q44069585 | Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice |
| Q81097777 | Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression |
| Q35929384 | Paternal RLIM/Rnf12 is a survival factor for milk-producing alveolar cells |
| Q37364696 | Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis |
| Q34801773 | Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland. |
| Q28729079 | Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors |
| Q48926254 | Prediction of transgene integration by noninvasive bioluminescent screening of microinjected bovine embryos |
| Q36123672 | Pregnancy and stem cell behavior |
| Q35192742 | Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk |
| Q44409381 | Proteotyping of Mammary Tissue from Transgenic and Gene Knockout Mice with Immunohistochemical Markers: a Tool To Define Developmental Lesions |
| Q28602310 | Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas |
| Q39670403 | RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. |
| Q42935431 | RU486-inducible recombination in the salivary glands of lactoferrin promoter-driven green fluorescent Cre transgenic mice |
| Q35240492 | RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. |
| Q30496322 | Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status |
| Q37478749 | Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis |
| Q30419961 | Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice |
| Q35683608 | Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation |
| Q35417300 | Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice |
| Q36949096 | Reprogramming stem cells is a microenvironmental task |
| Q51102156 | Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus. |
| Q47411248 | Reversed end Ds element: a novel tool for chromosome engineering in Arabidopsis |
| Q37695777 | Reversible transdifferentiation of secretory epithelial cells into adipocytes in the mammary gland |
| Q39892896 | Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication |
| Q34363614 | Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice |
| Q33860834 | Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation |
| Q34258504 | Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer |
| Q27315980 | Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland |
| Q90661038 | Scribble promotes alveologenesis in the pregnant mammary gland for milk production |
| Q24547568 | Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells |
| Q34820264 | Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium |
| Q33657413 | Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis |
| Q36580933 | Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration |
| Q35761138 | Shp2 signaling suppresses senescence in PyMT-induced mammary gland cancer in mice. |
| Q34434909 | Signaling pathways in mammary gland development. |
| Q54462818 | Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. |
| Q51997629 | Socs 3 modulates the activity of the transcription factor Stat3 in mammary tissue and controls alveolar homeostasis. |
| Q48870288 | Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. |
| Q42521880 | Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia |
| Q35056355 | Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. |
| Q37713579 | Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis. |
| Q27023444 | Strategies to achieve conditional gene mutation in mice |
| Q52544495 | Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. |
| Q35764397 | T cell- but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer |
| Q92740008 | TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh |
| Q33955287 | TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis |
| Q34571586 | TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution |
| Q36476219 | Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer |
| Q37379679 | Targeting janus kinase 2 in Her2/neu-expressing mammary cancer: Implications for cancer prevention and therapy |
| Q40717361 | Targeting mammary epithelial cells using a bacterial artificial chromosome |
| Q47962163 | Techniques for the Reprogramming of Exogenous Stem/Progenitor Cell Populations Towards a Mammary Epithelial Cell Fate. |
| Q37194214 | Telomerase and estrogen-sensing activities are essential for continued mammary growth in vivo but dispensable for "reprogramming" neural stem cells |
| Q73143435 | Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice |
| Q33835605 | Temporally and spatially controlled expression of transgenes in embryonic and adult tissues. |
| Q33650414 | Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis |
| Q34170839 | The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner |
| Q36953001 | The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells |
| Q38302448 | The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells |
| Q36888347 | The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency |
| Q91816605 | The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex |
| Q37122729 | The THO ribonucleoprotein complex is required for stem cell homeostasis in the adult mouse small intestine |
| Q77759873 | The aryl hydrocarbon receptor (AhR) and its nuclear translocator (Arnt) are dispensable for normal mammary gland development but are required for fertility |
| Q33652431 | The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells |
| Q54122849 | The cJUN NH2-terminal kinase (JNK) pathway contributes to mouse mammary gland remodeling during involution. |
| Q54977412 | The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation. |
| Q42492889 | The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy |
| Q24630889 | The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development |
| Q84395807 | The high-level expression of human tissue plasminogen activator in the milk of transgenic mice with hybrid gene locus strategy |
| Q36937069 | The mammary microenvironment alters the differentiation repertoire of neural stem cells |
| Q36577825 | The miR-17/92 cluster is targeted by STAT5 but dispensable for mammary development. |
| Q35861709 | The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate. |
| Q36388077 | The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells |
| Q27851848 | The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis |
| Q37587063 | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis |
| Q35657873 | The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium |
| Q73143411 | The right time and place for molecular scissors |
| Q34978975 | The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells |
| Q35067253 | The role of prolactin in mammary carcinoma |
| Q90695287 | The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche |
| Q57184205 | The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression |
| Q100750439 | The transcription factor Sox10 is an essential determinant of branching morphogenesis and involution in the mouse mammary gland |
| Q37617637 | The use of the Cre/loxP system to study oxidative stress in tissue-specific manganese superoxide dismutase knockout models |
| Q64114526 | Therapeutic targeting of and mutant breast cancer through mutant p53 reactivation |
| Q40519923 | Tissue-selective expression of a conditionally-active ROCK2-estrogen receptor fusion protein. |
| Q64958992 | Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4. |
| Q34114603 | Transgenic animal bioreactors |
| Q34462948 | Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues |
| Q34580724 | Tumor formation in Brca1 conditional mutant mice |
| Q35787307 | Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity |
| Q73934720 | Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice |
| Q100395406 | Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis |
| Q64062896 | VANGL2 regulates luminal epithelial organization and cell turnover in the mammary gland |
| Q34402467 | VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms |
| Q33816341 | VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis |
| Q38883916 | Validation of an in vitro model of erbB2(+) cancer cell redirection |
| Q41297946 | WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis |
| Q48181517 | Xanthine oxidoreductase mediates membrane docking of milk-fat droplets but is not essential for apocrine lipid secretion. |
| Q91846499 | ZBTB7A governs estrogen receptor alpha expression in breast cancer |
| Q35222270 | c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. |
| Q41252362 | microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer |
| Q37631190 | p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis |
Search more.